Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Anticancer Research · 2025
DOI: 10.21873/anticanres.17897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yutaka Takahara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kanazawa Medical University, Uchinada, Japan takahara@kanazawa-med.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Immune Checkpoint Inhibitors, Lung Neoplasms.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Kanazawa Medical University, Uchinada, Japan takahara@kanazawa-med.ac.jp.
- Department of Respiratory Medicine, Kanazawa Medical University, Uchinada, Japan.
Zitieren
APA
Takahara, Y., Abe, R., Nagae, S., Tanaka, T., Ishige, Y., Shionoya, I., Yamamura, K., Nojiri, M., & Iguchi, M. (2025). Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Anticancer Research. https://doi.org/10.21873/anticanres.17897
Vancouver
Takahara Y, Abe R, Nagae S, Tanaka T, Ishige Y, Shionoya I, et al. Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Anticancer Research. 2025. doi:10.21873/anticanres.17897
BibTeX
@article{Takahara2025,
author = {Takahara, Yutaka and Abe, Ryudai and Nagae, Sumito and Tanaka, Takuya and Ishige, Yoko and Shionoya, Ikuyo and Yamamura, Kouichi and Nojiri, Masafumi and Iguchi, Masaharu},
title = {Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17897}
}
EUVIMED